AstraZeneca plans direct listing on New York Stock Exchange but isn’t quitting London

UK’s biggest drugmaker will put its US shares on a par with its London-based stock but says HQ will stay in Cambridge

Published: September 29, 2025 10:32 am

Source: The Guardian — Read original